Navigation Links
Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
Date:2/27/2008

114,420 133,812

Goodwill 78,431 78,431

Other intangible assets, net 2,680 3,626

Other assets 6,289 8,932

Total assets $725,103 $768,177

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $3,589 $7,205

Accrued compensation 14,680 12,994

Accrued expenses to contract

manufacturers 40,444 -

Accrued expenses 12,446 17,942

Interest payable 2,638 3,814

Capital lease obligations, current

portion 2,335 711

Deferred revenue, current portion 19,620 16,409

Convertible subordinated notes,

current portion - 102,653

Other current liabilities 2,340 3,854

Total current liabilities 98,092 165,582

Convertible subordinated notes 315,000 315,000

Capital lease obligations 21,632 19,759

Deferred revenue 61,349 23,697

Other long-term liabilities 14,591 17,079

Total liabilites 510,664 541,117

Commitments and contingencies

Stockholders' equity:

Preferred stock - -

Common stock 9 9

Capital in excess of par value 1,302,541 1,283,982

Accumulated other comprehensive

income
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
2. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
3. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
4. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
6. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
7. Prime Therapeutics Receives TIPPS Certification
8. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
9. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
10. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
11. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... , NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ ...erious and often deadly blood cancers. Research pr...erican Society of Hematology introduces potential ...ods for patients suffering from acute promyelocyti... lymphoblastic leukemia, and myelofibrosis that ar...
(Date:12/5/2009)... AVIVA today announced the launch of...ational private medical insurance plan which follo...nt. In addition to offering customers the flexibil...it their needs and budgets, International Solution...mplement those already offered in their country of...
(Date:12/4/2009)...NEW YORK, Dec. 4 Care I...e "Company") today announced that its Board of Dir...of common stock. The dividend is payable on Decem...ecember 14, 2009. ,, About Care Investment ...estate investment and finance company investing in...
(Date:12/4/2009)...WASHINGTON, Dec. 4 The ... Aging (AAHSA) applauds the Senate for ensuring th...CLASS) provisions remain in the final health refor... for providing support to elders, people with disa...Senate to pass a health care reform bill that will...
(Date:12/4/2009)..., ANAHEIM, Calif., Dec. 4 Pamela ...hcare, was selected as a finalist for the "Chief I...scent,s business with the power of cloud computing...ir innovative usage of Salesforce CRM or the Force...uccess to their sales, marketing, partner, service...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... Colorado Court of Appeals handed,State Farm Mutua...ng a,trial-court ruling supporting the insurance g...mbursements of medical costs. The ruling, issued ...unilaterally reduced after the insurance,company p...
...rogen Pharmaceuticals,Limited (ASX: PGL; Nasdaq: P...-cancer drug PI-88 has been awarded Fast Track sta.... The fast track designation has been granted,to P... Under the FDA Modernization Act of 1997, the fas...
... Benjamin England,Special Counsel with Jones Walke...ture, Rural Development, Food and Drug Administrat...on Appropriations, on Tuesday, September,25, 2007 ...ategic Plan that relates to the import of food, dr...
...24 While most patients and physicians believe its...xam, theres growing debate about this conventional...ue of the Archives of Internal Medicine raises ser... the number, cost and content of preventive health...
...epressed, distraught were seldom questioned, study...s) -- Pointing to a disconnect between doctors and...ests that large numbers of physicians fail to spot...r a similar disorder. , Only 36 percent of the doc...
... Today, Speaker of the,House Nancy Pelosi (D-CA) a...d Louise Slaughter (D-NY), introduced the Coordina...7. This legislation would establish a,national pub...ards, and increase funding for locally-based pilot...
Other Medicine News:Health News:Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces 2Health News:Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces 3Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 2Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 3Health News:Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee 2Health News:New study likely to fuel debate over annual physical exams 2Health News:New study likely to fuel debate over annual physical exams 3Health News:Doctors Often Fail to Spot Suicidal Patients 2Health News:Doctors Often Fail to Spot Suicidal Patients 3Health News:Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation 2
(Date:12/3/2009)...DALE, Pa., Dec. 3 Radiology imagin...-record integration capabilities at the November 2... The Connect.PACS(TM) product, enabling the fir... is the latest release in the company,s newly bran...Photo: http://www.newscom.com/cgi-bin/prnh/20091...
(Date:12/3/2009)...RSHOLM, Denmark and SAN DIEGO, California, Decembe...lly Inhibits miR-122, a microRNA Important for,Hep...Reducing Hepatitis C,Virus in the Bloodstream in C... C Virus , - SPC3649 Demonstrates Efficac...ous Adverse Events in the Treated Animals - Signal...
(Date:12/3/2009)...ec. 3 In response to th...tion technologies in the evolving healthcare deliv...ter for Health Informatics (DCHI) to provide a cam...e an innovative interdisciplinary approach to educ...ians, nurses and healthcare administrators with an...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Par Pharmaceutical Receives Final Approval to Market Generic Ultram 28R 29 ER 6276 1Par Pharmaceutical Receives Final Approval to Market Generic Ultram 28R 29 ER 6276 2Lilly Surpasses United Way 2009 Campaign Goal 6272 1Lilly Surpasses United Way 2009 Campaign Goal 6272 2Lilly Surpasses United Way 2009 Campaign Goal 6272 3Raleigh Day Spa Blue Water Spa Raffles Off 2410 000 in Day Spa Packages for Contributing to Raleigh Food Drive 61407 1Raleigh Day Spa Blue Water Spa Raffles Off 2410 000 in Day Spa Packages for Contributing to Raleigh Food Drive 61407 2
...stic Systems, Inc. (OTC Bulletin Board: SSUR) toda...ent from Inverness Medical Innovations, Inc.,(Amex...ure and Inverness,signed two additional agreements...reby Inverness acquired an option to the exclusive...ertain infectious disease diagnostic,tests develop...
...ERN, Pa., Oct. 17 Cutanea Life Sciences, an,emerg...proving human health,and appearance through the de...diseased and aging skin conditions, today announce...al of Omiganan. The trial compared Omiganan 2.5% ...ulopustular rosacea. Study results demonstrated th...
Other Medicine Technology:StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 3Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 2Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 3Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 4Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 5Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 6
Buratto Insertion Forceps - Angled
Hydroview Insertion Forceps - Titanium
Hydro Insertion Forceps
Kellan Lens Inserter Forceps
Medicine Products: